Thank you very much.
I want to thank the witnesses for participating in our meeting today.
I have three questions, which I will ask right away, so that you can then answer them.
Ms. Giudice-Tompson, thank you very much for your testimony. I have read the recommendations you sent us. However, you did not talk very much about one of them during your testimony. So I would like to give you an opportunity to do so. I am talking about the third recommendation, which consists of the “abolition of specific marketing practices for prescription drugs with potential for abuse”. Could you elaborate on that?
Ms. Ulan, at the end of your testimony, you requested funding. Can you tell us exactly how much money you want and how you intend to use it?
My last question is for Mr. MacPherson.
At the beginning of your testimony, you talked about why opioid consumption is growing. I thought that was very significant. We are told that there is not much data on that issue. When answering a question from our parliamentary secretary, Ms. Ulan talked about Ritalin. She said that all kinds of people use it—young people, students, and so on.
Is any data currently available on that issue? If we were to conduct a study on the causes, where should we begin? How long would the study take and what kind of a sample would be needed?
I will let you answer. Perhaps you could each take one minute.